Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8675679 [patent_doc_number] => 08383793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/761050 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 39365 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12761050 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/761050
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors Apr 14, 2010 Issued
Array ( [id] => 6273170 [patent_doc_number] => 20100255514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'TUMOR CELL-DERIVED MICROVESICLES' [patent_app_type] => utility [patent_app_number] => 12/759378 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14616 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255514.pdf [firstpage_image] =>[orig_patent_app_number] => 12759378 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/759378
TUMOR CELL-DERIVED MICROVESICLES Apr 12, 2010 Abandoned
Array ( [id] => 6498531 [patent_doc_number] => 20100286179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'EGFR POLYMORPHISMS PREDICT GENDER-RELATED TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/758763 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 26281 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286179.pdf [firstpage_image] =>[orig_patent_app_number] => 12758763 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/758763
EGFR polymorphisms predict gender-related treatment Apr 11, 2010 Issued
Array ( [id] => 6339300 [patent_doc_number] => 20100247438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'IN VITRO METHOD FOR DIAGNOSING TUMOR DISEASES' [patent_app_type] => utility [patent_app_number] => 12/731499 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5200 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247438.pdf [firstpage_image] =>[orig_patent_app_number] => 12731499 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/731499
IN VITRO METHOD FOR DIAGNOSING TUMOR DISEASES Mar 24, 2010 Abandoned
Array ( [id] => 6433782 [patent_doc_number] => 20100278821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'N-CADHERIN: TARGET FOR CANCER DIAGNOSIS AND THERAPY' [patent_app_type] => utility [patent_app_number] => 12/730862 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 28294 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278821.pdf [firstpage_image] =>[orig_patent_app_number] => 12730862 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/730862
N-CADHERIN: TARGET FOR CANCER DIAGNOSIS AND THERAPY Mar 23, 2010 Abandoned
Array ( [id] => 7489657 [patent_doc_number] => 08029981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma' [patent_app_type] => utility [patent_app_number] => 12/726964 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20821 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/029/08029981.pdf [firstpage_image] =>[orig_patent_app_number] => 12726964 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/726964
Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma Mar 17, 2010 Issued
Array ( [id] => 6513789 [patent_doc_number] => 20100216696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Compounds and methods for treating cancer' [patent_app_type] => utility [patent_app_number] => 12/661356 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18370 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216696.pdf [firstpage_image] =>[orig_patent_app_number] => 12661356 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/661356
Compounds and methods for treating cancer Mar 15, 2010 Issued
Array ( [id] => 6513789 [patent_doc_number] => 20100216696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Compounds and methods for treating cancer' [patent_app_type] => utility [patent_app_number] => 12/661356 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18370 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216696.pdf [firstpage_image] =>[orig_patent_app_number] => 12661356 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/661356
Compounds and methods for treating cancer Mar 15, 2010 Issued
12/661314 Compounds and methods for treating cancer Mar 14, 2010 Abandoned
Array ( [id] => 6095445 [patent_doc_number] => 20110002978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'ENZYME PRODRUG CANCER THERAPY SELECTIVELY TARGETED TO TUMOR CELLS OR TUMOR VASCULATURE AND METHODS OF PRODUCTION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/721125 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15809 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002978.pdf [firstpage_image] =>[orig_patent_app_number] => 12721125 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/721125
ENZYME PRODRUG CANCER THERAPY SELECTIVELY TARGETED TO TUMOR CELLS OR TUMOR VASCULATURE AND METHODS OF PRODUCTION AND USE THEREOF Mar 9, 2010 Abandoned
Array ( [id] => 6580961 [patent_doc_number] => 20100291068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'NUCLEIC ACID MOLECULES AND PROTEINS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 12/719554 [patent_app_country] => US [patent_app_date] => 2010-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38605 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291068.pdf [firstpage_image] =>[orig_patent_app_number] => 12719554 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/719554
NUCLEIC ACID MOLECULES AND PROTEINS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF OVARIAN CANCER Mar 7, 2010 Abandoned
Array ( [id] => 8158435 [patent_doc_number] => 20120100144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'Biomarker and Treatment for Cancer' [patent_app_type] => utility [patent_app_number] => 13/254127 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15968 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100144.pdf [firstpage_image] =>[orig_patent_app_number] => 13254127 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/254127
Biomarker and Treatment for Cancer Mar 1, 2010 Abandoned
Array ( [id] => 8477754 [patent_doc_number] => 20120277161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'INHIBITION OF MULTIPLE CELL ACTIVATION PATHWAYS' [patent_app_type] => utility [patent_app_number] => 13/202843 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23429 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202843 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/202843
INHIBITION OF MULTIPLE CELL ACTIVATION PATHWAYS Feb 22, 2010 Abandoned
Array ( [id] => 7807248 [patent_doc_number] => 20120058202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'Means and Method for Ovarian Cancer Prognosis' [patent_app_type] => utility [patent_app_number] => 13/201740 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 31744 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058202.pdf [firstpage_image] =>[orig_patent_app_number] => 13201740 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/201740
Means and Method for Ovarian Cancer Prognosis Feb 15, 2010 Abandoned
Array ( [id] => 8701377 [patent_doc_number] => 08394598 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Tyrosine kinome' [patent_app_type] => utility [patent_app_number] => 12/705760 [patent_app_country] => US [patent_app_date] => 2010-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4943 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12705760 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/705760
Tyrosine kinome Feb 14, 2010 Issued
Array ( [id] => 6519156 [patent_doc_number] => 20100203054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Wnt Proteins and Detection and Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 12/701425 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20909 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203054.pdf [firstpage_image] =>[orig_patent_app_number] => 12701425 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/701425
Wnt Proteins and Detection and Treatment of Cancer Feb 4, 2010 Abandoned
Array ( [id] => 6262871 [patent_doc_number] => 20100297158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'ANTICANCER VACCINE AND DIAGNOSTIC METHODS AND REAGENTS' [patent_app_type] => utility [patent_app_number] => 12/698822 [patent_app_country] => US [patent_app_date] => 2010-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12545 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297158.pdf [firstpage_image] =>[orig_patent_app_number] => 12698822 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/698822
Anticancer vaccine and diagnostic methods and reagents Feb 1, 2010 Issued
Array ( [id] => 6632054 [patent_doc_number] => 20100173341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'APOPTOSIS-BASED EVALUATION OF CHEMOSENSITIVITY IN CANCER PATIENTS' [patent_app_type] => utility [patent_app_number] => 12/689761 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6736 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173341.pdf [firstpage_image] =>[orig_patent_app_number] => 12689761 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/689761
APOPTOSIS-BASED EVALUATION OF CHEMOSENSITIVITY IN CANCER PATIENTS Jan 18, 2010 Abandoned
Array ( [id] => 6631766 [patent_doc_number] => 20100173314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'DIAGNOSTIC METHODS USING TENASCIN-W COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/688363 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13804 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173314.pdf [firstpage_image] =>[orig_patent_app_number] => 12688363 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/688363
DIAGNOSTIC METHODS USING TENASCIN-W COMPOSITIONS Jan 14, 2010 Abandoned
Array ( [id] => 6232067 [patent_doc_number] => 20100184843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'IDENTIFICATION OF A PIN SPECIFIC GENE AND PROTEIN (PIN-1) USEFUL AS A DIAGNOSTIC TREATMENT FOR PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 12/683927 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 30817 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184843.pdf [firstpage_image] =>[orig_patent_app_number] => 12683927 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/683927
IDENTIFICATION OF A PIN SPECIFIC GENE AND PROTEIN (PIN-1) USEFUL AS A DIAGNOSTIC TREATMENT FOR PROSTATE CANCER Jan 6, 2010 Abandoned
Menu